Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
ZURA Zura Bio Ltd
- Stocks
- Healthcare
- NASDAQ: ZURA
Price (delayed)
$1.13
Market cap
$69.92M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.7
Enterprise value
-$100.65M
zura bio is a clinical-stage biotechnology company advancing zb-168 in alopecia areata and other inflammatory diseases. zb-168 is an anti il7rα inhibitor that has the potential to impact diseases driven
Highlights
The company's equity has surged by 127% YoY but it fell by 6% QoQ
The EPS is up by 49% year-on-year but it is down by 17% since the previous quarter
ZURA's net income is down by 19% since the previous quarter and by 6% year-on-year
Key stats
What are the main financial stats of ZURA
Market
Valuations
Earnings
Shares outstanding
61.87M
Market cap
$69.92M
Enterprise value
-$100.65M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.56
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$66.06M
Net income
-$62.1M
EBIT
-$62.1M
EBITDA
-$62.08M
Free cash flow
-$34.27M
Per share
Balance sheet
Liquidity
EPS
-$0.7
EPS diluted
-$0.7
Free cash flow per share
-$0.37
Book value per share
$2.02
Revenue per share
$0
TBVPS
$1.86
Total assets
$172.5M
Total liabilities
$21.09M
Debt
$0
Equity
$138.2M
Working capital
$150.6M
Debt to equity
0
Current ratio
8.14
Quick ratio
8.09
Net debt/EBITDA
2.75
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-34%
Return on equity
-41.8%
Return on invested capital
N/A
Return on capital employed
-41%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ZURA stock price
How has the Zura Bio stock price performed over time
Intraday
0.89%
1 week
-1.74%
1 month
5.61%
1 year
-67.81%
YTD
-54.8%
QTD
7.62%
Financial performance
How have Zura Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$66.06M
Net income
-$62.1M
Gross margin
N/A
Net margin
N/A
The operating income fell by 20% QoQ and by 4.4% YoY
ZURA's net income is down by 19% since the previous quarter and by 6% year-on-year
Price vs fundamentals
How does ZURA's price correlate with its fundamentals
Growth
What is Zura Bio's growth rate over time
Valuation
What is Zura Bio stock price valuation
P/E
N/A
P/B
0.56
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS is up by 49% year-on-year but it is down by 17% since the previous quarter
The company's equity has surged by 127% YoY but it fell by 6% QoQ
The price to book (P/B) is 49% less than the last 4 quarters average of 1.1
Efficiency
How efficient is Zura Bio business performance
Zura Bio's ROE has soared by 56% YoY but it has decreased by 19% from the previous quarter
The return on assets is up by 42% year-on-year but it has declined by 21% since the previous quarter
Dividends
What is ZURA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ZURA.
Financial health
How did Zura Bio financials performed over time
The total assets has soared by 91% YoY but it fell by 3.9% QoQ
The quick ratio is up by 32% year-on-year but it has declined by 11% since the previous quarter
The debt is 100% smaller than the equity
The company's equity has surged by 127% YoY but it fell by 6% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.